Day: December 18, 2019

Publications financièresLe Kremlin-Bicêtre, le 18 décembre 2019IT Link, première Entreprise de Services du Numérique spécialiste des systèmes connectés, est cotée au compartiment C EURONEXT Paris (ISIN FR0000072597).Contacts :Presse                                contact.presse@itlink.frAnalystes/investisseurs        info.invest@itlink.frPlus d’informations              www.itlink.frPièce jointeGroupe IT Link – Calendrier financier 2020

IRVINE, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) —  In the release distributed Friday, December 13, 2019 by ShiftPixy, Inc., we were informed the first bullet of the press release in ‘2019 Financial Highlights’ should read “Loss per share improved to $0.57 in 2019 compared to $0.58 for 2018.” Completed corrected text follows.ShiftPixy, Inc. (NASDAQ: PIXY), a California-based staffing enterprise that designs, manages, and sells access to a disruptive, revolutionary platform that facilitates employment in the rapidly growing Gig Economy, today announced operating results for the year ended August 31, 2019 (“2019”).2019 Financial HighlightsLoss per share improved to $0.57 in 2019 compared to $0.58 for 2018.Gross billings grew 59% to $353 million, compared to $222 million for 2018. ...

Safety primary objective of the study met Positive results observed regarding the efficacy of odiparcil, especially inhard- to-reach tissues Decision to continue the clinical development of odiparcil for the treatment of mucopolysaccharidosis (MPS) type VI Study results to be presented during a dedicated conference call and webcast on December 19, 2019Daix (France), December 18, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal storage disorders and oncology, today announced the results from its Phase IIa iMProveS (improve MPS treatment) clinical study evaluating odiparcil for the treatment of mucopolysaccharidosis (MPS) type VI, a rare, progressive genetic disorder with high unmet...

L’objectif principal de démonstration d’un bon profil de sécurité a été atteint   Résultats positifs concernant l’efficacité d’odiparcil, en particulier dans des tissus difficile à atteindre par les traitements médicamenteux Décision de poursuivre le développement clinique d’odiparcil dans le traitement de la mucopolysaccharidose (MPS) de type VI Les résultats de l’étude seront présentés lors d’une conférence téléphonique et d’un webcast le 19 décembre 2019Daix (France), le 18 décembre 2019 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de...

On 18 December 2019 the board of AB Nasdaq Vilnius has adopted the decision to introduce to trading on regulated market (AB Nasdaq Vilnius Bond list) all 20,000 units of green bonds of AUGA group, AB (the “Company”) with a nominal value of EUR 1,000 each, issued under the base prospectus, approved by the Bank of Lithuania on 25 November 2019 and under the Final Terms (the “Final Terms”) of Tranche 1 of bonds (respective decisions of the Board of the Company were adopted on 22 and 25 November 2019 as well as on 5 December 2019, the “Bonds”).In addition to that on 18 December 2019 the Company has signed all the needed documentation with the Bond trustee UAB “Audifina” establishing a security package (land mortgage) in favour of the Bondholders, as indicated in the Final Terms.The person...

2019 m. gruodžio 18 d. AB Nasdaq Vilnius valdyba priėmė sprendimą įtraukti į prekybą reguliuojamoje rinkoje (AB Nasdaq Vilnius skolos VP sąraše) visus 20 000 vnt. AUGA group, AB (toliau – Bendrovė) žaliųjų obligacijų, kurių kiekvienos nominali vertė 1 000 EUR, išleistų pagal 2019 m. lapkričio 25 d. Lietuvos banko patvirtintą bazinį prospektą, taip pat pagal galutines 1 dalies obligacijų sąlygas (toliau – Galutinės sąlygos) (atitinkami Bendrovės valdybos sprendimai priimti 2019 m. lapkričio 22 ir 25 d., taip pat 2019 m. gruodžio 5 d., toliau – Obligacijos).Be to, 2019 m. gruodžio 18 d. Bendrovė su Obligacijų...

Paris, France, December 18, 2019Atos, a global leader in digital transformation, today announced an agreement to acquire Maven Wave, a U.S.-based business and technology consulting firm specialized in delivering digital transformation solutions for large enterprises. The company is a leading Google Cloud Premier Partner with eight Cloud Partner Specializations and recognized as the Google Cloud North America Services Partner of the year in both 2018 and 2019.  The purchase embeds Maven Wave’s strengths in building digital solutions using cloud-based applications, data analytics and machine learning in hybrid and multi-cloud platforms with Atos’ proven leadership in Hybrid Cloud, SAP HANA, Application Modernization and Transformation, Digital Workplace, IoT and Analytics.“The acquisition of Maven Wave, coupled with...

Paris, France, le 18 Décembre 2019Atos, leader international de la transformation digitale, annonce aujourd’hui la conclusion d’une entente visant l’acquisition de Maven Wave, une société américaine de conseil en technologie spécialisée dans la prestation de solutions de transformation numérique pour les grandes entreprises. La société est l’un des principaux partenaires de Google Cloud avec huit spécialisations ‘Cloud Partner’ et a été reconnue ‘partenaire de services Google Cloud de l’année’ pour l’Amérique du Nord en 2018 et 2019. Cette acquisition intègre les atouts de Maven Wave en matière de développement de solutions numériques utilisant des...

Birting fjárhagsupplýsinga mun eiga sér stað eftir lokun markaða.Nánari upplýsingar veitir:Helgi S. Gunnarsson – Forstjóri – helgi@reginn.is – S: 512 8900 / 899 6262

TORONTO, Dec. 18, 2019 (GLOBE NEWSWIRE) — Hexagon Energy Materials Limited (ASX:HXG) (“HXG”, “Hexagon” or the “Company”) is pleased to announce that it has commenced funding of the Phase-One commercialization of RapidSX™ rare-earth element (“REE”) separation technology for REE concentrates.Per HXG’s October 10, 2019 ASX announcement (“Hexagon Enters US-based Rare Earth Downstream Processing Industry”), the Company has executed a binding Investment Agreement whereby Hexagon has secured an option to acquire a 49% interest in RapidSX™ for REEs – an advanced, proprietary low-cost downstream REE separation technology developed and piloted by Innovation Metals Corp. (“IMC”). With US$1.8 million in funding assistance from the US Department...